Dieckol and Its Derivatives as Potential Inhibitors of SARS-CoV-2 Spike Protein (UK Strain: VUI 202012/01): A Computational Study

The high risk of morbidity and mortality associated with SARS-CoV-2 has accelerated the development of many potential vaccines. However, these vaccines are designed against SARS-CoV-2 isolated in Wuhan, China, and thereby may not be effective against other SARS-CoV-2 variants such as the United King...

Descripción completa

Detalles Bibliográficos
Autores principales: Aatif, Mohammad, Muteeb, Ghazala, Alsultan, Abdulrahman, Alshoaibi, Adil, Khelif, Bachir Yahia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145291/
https://www.ncbi.nlm.nih.gov/pubmed/33922914
http://dx.doi.org/10.3390/md19050242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145291/
https://www.ncbi.nlm.nih.gov/pubmed/33922914
http://dx.doi.org/10.3390/md19050242

Ejemplares similares